期刊文献+

氨溴特罗口服液联合肺力咳合剂对小儿痉挛性咳嗽的治疗效果 被引量:3

Effect of ambroxol oral solution combined with Feilike mixture in the treatment of children with spasmodic cough
下载PDF
导出
摘要 目的探讨氨溴特罗口服液联合肺力咳合剂治疗小儿痉挛性咳嗽的临床效果。方法选取我院儿科诊治的痉挛性咳嗽患儿100例,将其随机分成对照组(52例,常规综合治疗)和观察组(48例,在对照组的基础上加用氨溴特罗联合肺力咳合剂治疗)。比较两组的临床疗效。结果观察组治疗总有效率明显高于对照组,差异具有统计学意义(P<0.05);观察组喘憋、咳嗽、肺部干鸣消退时间均明显短于对照组(P<0.05);用药后,两组患儿均未见明显不良反应发生。结论盐酸氨溴特罗口服溶液及肺力咳合剂在小儿痉挛性咳嗽的治疗中效果显著,可明显改善患儿临床症状,且安全可靠,值得临床推广。 Objective To explore the clinical effect of ambroxol oral solution combined with Feilike mixture in thetreatment of children with spastic cough. Methods A total of 100 children with spasmodic cough admitted in the pediatricsdepartment of our hospital were selected and randomly divided into control group (52 cases, routine comprehensivetreatment) and observation group (48 cases, ambroxol combined with Feilike mixture on the basis of the control group). Theclinical effects of the two groups were compared. Results The total effective rate of treatment in the observation group wassignificantly higher than that of the control group, the difference was statistically significant (P〈0.05). The disappearancetimes of asthma, cough and lung dry sounding in the observation group were significantly shorter than those in the controlgroup (P〈0.05). After treatment, there was no obvious adverse reactions occurred in the two groups. Conclusion Ambrocoloral solution and Feilike mixture is effective in the treatment of spastic cough in children, which can obviously improve theclinical symptoms of children, and is safe and reliable. It is worthy of clinical promotion.
作者 谭雪净 TAN Xue-jing(Pediatrics Department,South District of People's Hospital of Tongchuan,Tongchuan 727031,China)
出处 《临床医学研究与实践》 2018年第34期90-91,共2页 Clinical Research and Practice
关键词 小儿痉挛性咳嗽 氨溴特罗口服液 肺力咳合剂 spastic cough in children ambrocol oral solution Feilike mixture
  • 相关文献

参考文献9

二级参考文献25

  • 1黄素霞.联用维生素K_1治疗小儿喘息性疾病40例疗效观察[J].中原医刊,2005,32(10):48-49. 被引量:3
  • 2何学坤,何莲.酚妥拉明和维生素K_1治疗小儿毛细支气管炎疗效观察[J].右江医学,2005,33(4):399-399. 被引量:10
  • 3李荣.肺力咳合剂佐治小儿肺炎的疗效观察[J].医药论坛杂志,2007,28(8):71-72. 被引量:9
  • 4陈文彬.诊断学[M]第5版[M].北京:人民卫生出版社,2002.301.
  • 5胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:1171-1207.
  • 6胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 7康永,张静涛.肺力咳合剂治疗小儿急性支气管炎75例疗效观察[J].中医儿科杂志,2007,3(6):15-16. 被引量:14
  • 8Sigurs N, Bjamason R, Sigurbergason F, et al. Respiratory syneytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7 [J]. Am J Respir Crit Cure Med, 2000, 161(5): 1501-1507. [3] Bisgaard H, Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis [J]. Am J Respir Crit Care Med, 2003. 167(3): 379-383.
  • 9Bisgaard H, Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis [J]. Am J Respir Crit Care Med, 2003, 167(3): 379-383.
  • 10Keams GL, Lu S, Maganti L, et al. Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis [ J ]. J Clin Pharmacol, 2008, 48 (4) : 510-511.

共引文献70

同被引文献23

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部